Skip to main content
SpringerLink
Log in

Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials

  • Clinical Study - Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Neuropsychological tests are increasingly being used as outcome measures in clinical trials of brain tumor therapies. This study informs development of brief neurocognitive batteries for clinical trials by identifying cognitive tasks that detect effects on a group level in a mixed brain tumor population. This is a retrospective study of brain tumor patients who completed a standardized battery sampling multiple cognitive domains using twelve subtests with widely-used task formats (the Repeatable Battery for the Assessment of Neuropsychological Status). Sixty-eight patients with brain tumors were studied (60% high-grade glioma). Forty patients (58.8%) were impaired (>2 standard deviations below published means) on at least one subtest. A combination of four subtests (Figure Copy, Coding, List Recognition, and Story Recall) captured 90% of the impaired subgroup. These results suggest visuoconstruction, processing speed, and verbal memory measures may be the most important domains to assess when evaluating cognitive change in brain tumor clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

RBANS:

Repeatable Battery for the Assessment of Neuropsychological Status

CNS:

Central nervous system

SD:

Standard deviation

References

  1. Brown PD, Buckner JC, O’Fallon JR, Iturria NL, O’Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG (2004) Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 59:117–125

    PubMed  Google Scholar 

  2. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168

    Article  PubMed  Google Scholar 

  3. Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646–650

    CAS  PubMed  Google Scholar 

  4. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165

    Article  CAS  PubMed  Google Scholar 

  5. Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 5:89–95

    Article  PubMed  Google Scholar 

  6. Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24:1305–1309

    Article  PubMed  Google Scholar 

  7. Lehmann JF, DeLisa JA, Warren CG, deLateur BJ, Bryant PL, Nicholson CG (1978) Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. Arch Phys Med Rehabil 59:410–419

    CAS  PubMed  Google Scholar 

  8. Meyers CA, Boake C (1993) Neurobehavioral disorders in brain tumor patients: rehabilitation strategies. Cancer Bull 45:362–364

    Google Scholar 

  9. Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolbers JG, Karim AB (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372–376

    Article  CAS  PubMed  Google Scholar 

  10. Archibald YM, Lunn D, Ruttan LA, Macdonald DR, Del Maestro RF, Barr HW, Pexman JH, Fisher BJ, Gaspar LE, Cairncross JG (1994) Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247–253

    Article  CAS  PubMed  Google Scholar 

  11. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999

    CAS  PubMed  Google Scholar 

  12. Maire JP, Coudin B, Guerin J, Caudry M (1987) Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 10:156–162

    Article  CAS  PubMed  Google Scholar 

  13. Herman MA, Tremont-Lukats I, Meyers CA, Trask DD, Froseth C, Renschler MF, Mehta MP (2003) Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol 26:273–279

    Article  PubMed  Google Scholar 

  14. Li J, Bentzen SM, Renschler M, Mehta MP (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260–1266

    Article  PubMed  Google Scholar 

  15. Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA, Renschler MF (2002) Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20:3445–3453

    Article  CAS  PubMed  Google Scholar 

  16. Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, Gore EM, Franklin RLIII, Suh JH, Mehta MP (2004) Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 58:1346–1352

    Article  PubMed  Google Scholar 

  17. van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC (2007) Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84:271–278

    Article  PubMed  Google Scholar 

  18. Meyers CA, Wefel JS (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558

    Article  PubMed  Google Scholar 

  19. Randolph C (1998) Manual—Repeatable Battery for the Assessment of Neuropsychological Status. The Psychological Corporation, San Antonio, TX

    Google Scholar 

  20. Strauss E, Sherman EMS, Spreen O (2006) Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). In: A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York, NY, pp 237–258

  21. R Development Core Team (2008) R: A language and environment for statistical computing [Computer software]. R Foundation for Statistical Computing. Vienna, Austria. Retrieved from http://www.r-project.org

  22. Grant R, Slattery J, Gregor A, Whittle IR (1994) Recording neurological impairment in clinical trials of glioma. J Neurooncol 19:37–49

    Article  CAS  PubMed  Google Scholar 

  23. Weitzner MA, Meyers CA (1997) Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 6:169–177

    Article  CAS  PubMed  Google Scholar 

  24. Duff K, Leber WR, Patton DE, Schoenberg MR, Mold JW, Scott JG, Adams RL (2007) Modified scoring criteria for the RBANS figures. Appl Neuropsychol 14:73–83

    PubMed  Google Scholar 

Download references

Acknowledgements

Preliminary data from this study were presented at the 12th annual meeting of the Society for Neuro-Oncology, Dallas, Texas.

Author information

Authors and Affiliations

  1. Department of Rehabilitation Medicine, Emory University, 1441 Clifton Road NE, Suite 150, Atlanta, GA, 30322, USA

    Sarah K. Lageman

  2. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA

    Jane H. Cerhan

  3. Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ, USA

    Dona E. C. Locke

  4. Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA

    S. Keith Anderson & Wenting Wu

  5. Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA

    Paul D. Brown

Authors
  1. Sarah K. Lageman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jane H. Cerhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dona E. C. Locke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Keith Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wenting Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paul D. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah K. Lageman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lageman, S.K., Cerhan, J.H., Locke, D.E.C. et al. Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. J Neurooncol 96, 271–276 (2010). https://doi.org/10.1007/s11060-009-9960-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9960-y

Keywords

Search

Navigation